|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/165 | (2006.01) |
| A61K 31/197 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Number of the document | 2682114 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13187396.0 |
| Date of filing the European patent application | 2006-09-27 | |
| (97) | Date of publication of the European application | 2014-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 721722 P | 2005-09-28 | US |
| (72) |
Rao, Srinivas, G., US
Gendreau, Michael, US
Kranzler, Jay, D., US
|
| (73) |
Cypress Bioscience, Inc.,
4350 Executive Drive, Suite 325, San Diego, CA 92121,
US
|
| (54) | Milnacipran for the long-term treatment of fibromyalgia syndrome |
| Milnacipran for the long-term treatment of fibromyalgia syndrome |